Condition (MeSH)
Spotted Fever Group Rickettsiosis
ClinicalTrials.gov lists 4 trials for Spotted Fever Group Rickettsiosis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 4 trials are tagged with Spotted Fever Group Rickettsiosis itself; the rest are tagged with a narrower condition beneath it.
When did Spotted Fever Group Rickettsiosis trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 2 |
| 2020 | 1 |
| 2009 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Spotted Fever Group Rickettsiosis trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Observational | 3 |
How many Spotted Fever Group Rickettsiosis trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 1 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Spotted Fever Group Rickettsiosis? (1)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Seroepidemiology of rickettsial infections in Northeast India. | Transactions of the Royal Society of Tropical Medicine and Hygiene | 2016 | No |
Prevalence (4)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Rickettsialpox | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Rickettsialpox | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Rickettsialpox | Cases families | Worldwide | Not stated | Exact | |
| Rickettsialpox | Cases families | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Rickettsialpox | 83312 | Exact | Orphadata Science knowledge files, Product 1 |
| Rickettsialpox | 83312 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors and serious adverse events in this condition's trials.
Not computed for conditions with fewer than 10 trials: drugs tested.